Study subjects comprised 11 eyes in 11 patients (8 men, 3 women). Mean age was 73.6 ± 8.8 years (range, 50–86 years), and mean follow-up was 41.9 ± 8.0 days (range, 29–52 days). Mean best-corrected logMAR visual acuity at initial examination was 1.80 ± 0.82. Table 1 shows the characteristics of each patient.
BCVA, best-corrected visual acuity; N/A, not available; CF, count finger; HM, hand motion; HT, hypertension; ASO, Atherosclerosis obliterans; LS, light sense; DM, diabetes mellitus; Fern, fern-like pattern of hyporeflection; Diffuse, diffuse hyperreflection without fern-like pattern; DIV, intravenous Alprostadil Alfadex 40 µg for 3 days; PO, oral administration of Limaprost Alfadex for 1 month; OD, right eye; OS, left eye.
Acute-phase SS-OCT B-mode images revealed hyperreflectivity in the inner retinal layer in all cases. Mean retinal thicknesses of the CRAO-affected eye and unaffected eye were 259 ± 71 µm and 209 ± 25 µm at the central fovea (p = 0.101), 424 ± 86 µm and 305 ± 28 µm on the temporal side (p < 0.001), and 457 ± 121 µm and 318 ± 29 µm on the nasal side (p = 0.002), respectively. This indicated the presence of retinal thickening due to parafoveal retinal edema in the CRAO-affected eye. Acute-phase deep-layer en face images revealed overall hyperreflectivity in all cases, compared with the unaffected eye. In some patients, hyporeflective fern-like patterns aligned with arterioles in the arcade were apparent. The four patients (36%) who exhibited these fern-like patterns were grouped together as Group A (Figures 1-3), and the other seven (67%) as Group B (Figures 4,5).
A comparison of best-corrected visual acuity at initial examination in the two groups revealed that logMAR visual acuity was 1.21 ± 1.09 in Group A and 2.15 ± 0.24 in Group B, with a non-significant difference (p = 0.230), visual acuity at 1 month after onset was significantly better in Group A (0.02 ± 0.10) than in Group B (1.51 ± 0.44; p = 0.006) (Figure 6). A comparison of acute-phase retinal thicknesses in Groups A and B found that these were 230 ± 74 µm and 276 ±68 µm at the central fovea (p = 0.164), 371 ± 70 µm and 455 ± 79 µm on the temporal side (p = 0.109), and 381 ± 84 µm and 500 ± 118 µm on the nasal side (p = 0.109), respectively, with no significant differences between groups. Retinal thicknesses in Groups A and B at 1 month after onset were 221 ± 38 µm and 188 ± 25 µm at the central fovea (p = 0.230), 314 ± 36 µm and 251 ± 30 µm on the temporal side (p = 0.042), and 317 ± 35 µm and 260 ± 31 µm on the nasal side (p = 0.024), showing significantly thinning on the temporal and nasal side in Group B. In all patients, hyperreflectivity on deep-layer en face images had diminished at 1 month after onset, and now formed a mosaic pattern.